Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic cancer.

F R Bentley, I Cohn

    International Advances in Surgical Oncology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Pancreatic cancer lacks effective treatments and clear risk factors, despite increased incidence. Early diagnosis via tumor markers is crucial for improving patient survival rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dyschondroplasia.

    Annals of surgery·2010
    Same author

    Dyschondroplasia.

    Transactions of the Southern Surgical Association. Southern Surgical Association (U.S.)·2010
    Same author

    Ethical considerations in the early composite tissue allograft experience: a review of the Louisville Ethics Program.

    Transplantation proceedings·2005
    Same author

    Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men.

    International journal of clinical pharmacology and therapeutics·2004
    Same author

    Endowed chairs named for surgeons.

    Journal of the American College of Surgeons·2000
    Same author

    Early work in lymphatic mapping.

    Surgery·2000
    Same journal

    Adjuvant therapy for carcinoma of the colon and rectum.

    International advances in surgical oncology·1984
    Same journal

    Surgical treatment of thyroid cancer.

    International advances in surgical oncology·1984
    Same journal

    Advances in the treatment of testicular tumors.

    International advances in surgical oncology·1984
    Same journal

    Malignant esophageal tumors concomitant with benign esophageal diseases.

    International advances in surgical oncology·1984
    Same journal

    Vitamin A and retinoids: a hypothesis of tumour chemoprevention.

    International advances in surgical oncology·1984
    Same journal

    Recent patterns of malignant melanoma patient care in the United States.

    International advances in surgical oncology·1984
    See all related articles

    Area of Science:

    • Oncology
    • Gastroenterology

    Background:

    • Pancreatic cancer presents significant treatment challenges with unclear etiology and rising incidence in industrialized nations.
    • Despite diagnostic advancements, survival statistics for pancreatic cancer remain largely unchanged.
    • Current understanding of risk factors and specific at-risk populations for pancreatic cancer is limited.

    Purpose of the Study:

    • To highlight the urgent need for a reliable tumor marker for early pancreatic cancer diagnosis.
    • To review the current status and limitations of surgical interventions for pancreatic cancer.
    • To assess the early-stage exploration of radiotherapy and chemotherapy in pancreatic cancer management.

    Main Methods:

    • Review of current literature on pancreatic cancer treatment modalities.

    Related Experiment Videos

  • Analysis of survival statistics in relation to diagnostic and surgical advancements.
  • Evaluation of the role of palliative and adjuvant therapies in pancreatic cancer.

    • Main Results:

    • Radical surgery for pancreatic cancer has plateaued in improving survival, with observed benefits likely from improved perioperative care.
    • More aggressive surgical procedures have not yielded significant survival advantages.
    • Radiotherapy and chemotherapy are primarily used for palliation in advanced pancreatic cancer, with their utility as adjuncts to surgery undefined.

    Conclusions:

    • There is a critical need for novel diagnostic tools, such as tumor markers, to enable earlier detection of pancreatic cancer.
    • Current surgical techniques have reached their limit in improving pancreatic cancer survival.
    • Further systematic investigation into the role of radiotherapy and chemotherapy, both as primary treatments and as adjuncts to surgery, is required for pancreatic cancer.